Changeflow GovPing Pharma & Healthcare Randomized Controlled Trial of Dry Needling for...
Routine Notice Added Final

Randomized Controlled Trial of Dry Needling for Provoked Vestibulodynia

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

NIH registered a multicenter randomized controlled trial (NCT07534345) on ClinicalTrials.gov evaluating dry needling efficacy for provoked vestibulodynia (PVD), a chronic vulvar pain condition affecting up to 16% of women. The study will randomize 300 women to receive either real or sham dry needling over 8 weekly sessions, with outcomes assessed at baseline, post-treatment, and 6-month follow-up.

What changed

NIH registered a new clinical trial on ClinicalTrials.gov for a multicenter randomized controlled trial investigating dry needling as a treatment for provoked vestibulodynia (PVD). The study will enroll women experiencing chronic vulvar pain characterized by sharp pain at vaginal entry during penetration. Participants will be randomized 1:1 to receive either real dry needling targeting muscle tension or sham dry needling for 8 weekly sessions. The trial's primary outcome is pain reduction, measured using validated instruments at baseline, post-treatment, and 6-month follow-up.

For compliance officers and legal professionals, this registry entry indicates active clinical research in a therapeutic area with limited treatment options. The study addresses a condition affecting a significant portion of women and may generate data relevant to future clinical practice guidelines. No regulatory compliance obligations are created by this registry listing.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Efficacy of Dry Needling in Reducing Pain During Sexual Intercourse: a Randomized Controlled Trial

N/A NCT07534345 Kind: NA Apr 16, 2026

Abstract

Chronic vulvar pain is a highly prevalent and debilitating condition affecting up to 16% of women. The most common subtype of vulvar pain, provoked vestibulodynia (PVD), is characterized by a sharp pain at the entry of the vagina in response to pressure or attempted vaginal penetration. Women with PVD not only present with psychological distress and significant disruption in all aspects of sexual function, but they are also confronted with limited effective treatment options. Dry needling (DN) could fill this therapeutic gap. Similar to acupuncture, this approach involves the insertion of fine needles into the tissues. However, its mechanisms of action are quite different. DN specifically targets muscle tension/stiffness, which has been shown to play a key role in PVD. After designing a DN treatment protocol tailored to the affected muscles in PVD, our randomized pilot study confirmed that our state-of-the-art DN treatment protocol is feasible and acceptable for treating PVD and the promising findings obtained provide support for conducting the proposed large-scale study.

The proposed multicenter randomized controlled trial aims to establish the efficacy of DN for reducing pain in women with PVD. Women will be randomized to receive either sham or real DN for 8 weekly sessions. Validated outcome measures will be assessed at baseline, post-treatment and at the 6-month follow-up.

The current proposal addresses the urgent need to develop novel treatment options for women wit...

Conditions: Provoked Vestibulodynia

Interventions: Real dry needling, Sham dry needling

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07534345

Who this affects

Applies to
Clinical investigators Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Medical research Randomized controlled trial
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!